A Phase 2 Study of CIM331 for Atopic Dermatitis Patients

Clinical trial NCT01986933 · COMPLETED

Trial details

NCT number: NCT01986933
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2013-11-01
Primary completion: 2015-04-01
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.